We analyze stocks based on your inquiries and if we believe a stock has great potential, and we introduce small start-up companies, and other entrepreneurial ventures. In addition, we discuss ways to improve businesses, social media, and new technology in the business world.
Valuations for pharmaceutical companies should rebound once investors look past today's patent expirations to tomorrow's new drugs, says Morningstar's Damien Conover.
No comments:
Post a Comment